Jason Duncan
CIK 1741553 · See Remarks · last filed 2026-01-09
Jason Duncan is a corporate insider who has filed 27 SEC Form 4 insider transactions across 2 companies since 2018. The most recent filing, for NMRA, was dated Jan 9, 2026. Across all open-market trades the lifetime net is −$1.0M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
27
-$1.03M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NMRA | See Remarks | — | $1.78 | — | $0 | 4 | 2026-01-09 |
| ALBIREO PHARMA, INC. (ALBO) Delisted | Chief Legal Officer and GC | 0 | $44.15 | $0 | -$1.03M | 23 | 2023-03-02 |
Recent Filings
27 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-09 | NMRA | Grant (A) | — | $0 | EDGAR |
| 2025-05-30 | NMRA | Mixed | — | $0 | EDGAR |
| 2025-02-18 | NMRA | Mixed | — | $0 | EDGAR |
| 2023-12-12 | NMRA | Grant (A) | — | $0 | EDGAR |
| 2023-03-02 | ALBIREO PHARMA, INC. (ALBO) Delisted | Mixed | −3,296 | $0 | EDGAR |
| 2023-01-27 | ALBIREO PHARMA, INC. (ALBO) Delisted | Grant (A) | +55,000 | $0 | EDGAR |
| 2023-01-25 | ALBIREO PHARMA, INC. (ALBO) Delisted | Grant (A) | +55,000 | $0 | EDGAR |
| 2023-01-23 | ALBIREO PHARMA, INC. (ALBO) Delisted | Sell (S) | −228 | -$10.0K | EDGAR |
| 2023-01-20 | ALBIREO PHARMA, INC. (ALBO) Delisted | Sell (S) | −938 | -$41.2K | EDGAR |
| 2022-10-25 | ALBIREO PHARMA, INC. (ALBO) Delisted | Sell (S) | −656 | -$12.8K | EDGAR |